Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball | Zendy

Giorgia Montrucchio | Zendy; Silvia Corcione | Zendy; Gabriele Sales | Zendy; Antonio Curtoni | Zendy; Francesco Giuseppe De Rosa | Zendy; Luca Brazzi | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball

Author(s) -

Giorgia Montrucchio,

Silvia Corcione,

Gabriele Sales,

Antonio Curtoni,

Francesco Giuseppe De Rosa,

Luca Brazzi

Publication year - 2020

Publication title -

journal of global antimicrobial resistance

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.917

H-Index - 26

eISSN - 2213-7173

pISSN - 2213-7165

DOI - 10.1016/j.jgar.2020.11.004

Subject(s) - klebsiella pneumoniae , medicine , intensive care unit , ards , pandemic , covid-19 , acute respiratory distress , intensive care medicine , population , infectious disease (medical specialty) , disease , lung , biology , biochemistry , escherichia coli , gene , environmental health

Here we report on seven intensive care unit (ICU) patients with coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS) who developed positive rectal swabs and invasive infections due to carbapenemase-producing Klebsiella pneumoniae (CP-Kp). Notwithstanding the infection prevention measures introduced during the COVID-19 pandemic and changes in the hospitalised population, attention to CP-Kp infections must remain high, especially in the critically ill setting.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research